Portfolio

Hargol FoodTech

Delivering high-quality protein from edible locusts

Now Funding

Technology Development

Business Development

Revenue

Exited

Visit Website
Founded

2014
(incorporated 2016)

CEO
Dror Tamir
UN SDGs
2 12 13 15
Contact Us
email email
Follow Us
Investors
The Trendlines Group, Sirius Ventures (Singapore), SLJ Investment Partners (Holland), WeWork (United States)

About

We established Hargol FoodTech in 2016 with a mission to deliver better protein: A natural source of highly digestible complete protein, healthier for humans, more sustainable, safer and more efficient to produce. Co-Founder and CEO of Hargol, Dror Tamir’s vision is to lead the global protein revolution by doing better: creating a protein that has better nutrition and is healthier, more sustainable and richer in taste.

Hargol is a leader in the global alternative protein space, producing a nutrient-rich complete protein made from locusts. Hargol is the first company in the world to reach industrial scale production of locusts for protein. Hargol’s technology is mature, and the company has three production facilities operating in Israel. The infrastructure and technology are climate resilient, modular and quickly duplicated to meet any market demand.

Hargol’s novel ingredient is the perfect addition for improving human foods such as meat, pet food and feed.

Hargol has won over 20 awards worldwide.

video play icon
video link
10 advantages of locusts as a protein source

Market Need

Global food demand is growing while patterns of food consumption are changing towards more sustainable and healthier sources. To feed the expanding world population, the world is actively seeking high protein food from sustainable sources and at affordable costs.

Edible insects provide a high-quality protein alternative that is efficient to produce and requires minimal resources. Insects are an integral part of the diet of more than 2.5 billion people globally. With an increasing awareness of insects’ advantages in new food markets, there is a growing opportunity for quality insect products that can be mass produced efficiently and economically.

The U.S. protein ingredient market exceeds $35 billion (Nutrition Business Journal). By 2054, alternative protein will comprise 33% of the total protein market, with 50% from insects, algae, and bioengineered proteins (Lux Research). The edible insect business in Europe is projected to reach $380 million in 2020 (New Nutrition Business).

Skip to content